المؤلفون: Kawakami T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan. t.kawakami@scchr.jp., Todaka A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Oshima K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Fushiki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Hamauchi S; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Tsushima T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Yokota T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Onozawa Y; Division of Clinical Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Yasui H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.

المصدر: BMC cancer [BMC Cancer] 2023 Jan 20; Vol. 23 (1), pp. 68. Date of Electronic Publication: 2023 Jan 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols* , Fluorouracil*/therapeutic use , Irinotecan*/therapeutic use , Leucovorin*/therapeutic use , Pancreatic Neoplasms*/diagnosis , Pancreatic Neoplasms*/drug therapy , Biomarkers, Tumor*, Humans ; CA-19-9 Antigen ; Camptothecin ; Liposomes ; Retrospective Studies ; Treatment Outcome ; Pancreatic Neoplasms

المؤلفون: Shirasu H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Todaka A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Omae K; Clinical Research Promotion Unit, Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan., Fujii H; Department of Clinical Oncology, Jichi Medical University Hospital, Tochigi, Japan., Mizuno N; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan., Ozaka M; Department of Gastroenterology, The Cancer Institute Hospital of the Japanese Foundation For Cancer Research, Tokyo, Japan., Ueno H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan., Kobayashi S; Department of Gastroenterology, Division of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Kanagawa, Japan., Uesugi K; Departments of Gastroenterology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Kobayashi N; Department of Oncology, Yokohama City University Hospital, Kanagawa, Japan., Hayashi H; Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan., Sudo K; Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan., Okano N; Department of Medical Oncology, Faculty of Medicine, Kyorin University, Tokyo, Japan., Horita Y; Department of Chemotherapy and Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan., Kamei K; Departments of Surgery, Faculty of Medicine, Kindai University, Osaka, Japan., Yukisawa S; Departments of Medical Oncology, Tochigi Cancer Center, Tochigi, Japan., Kobayashi M; Clinical Trial Promotion Section, Shizuoka Industrial Foundation Pharma Valley Center, Shizuoka, Japan., Fukutomi A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.

المصدر: Cancer science [Cancer Sci] 2019 Feb; Vol. 110 (2), pp. 707-716. Date of Electronic Publication: 2018 Dec 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Fluorouracil/*therapeutic use , Glucuronosyltransferase/*genetics , Leucovorin/*therapeutic use , Organometallic Compounds/*therapeutic use , Pancreatic Neoplasms/*drug therapy , Pancreatic Neoplasms/*genetics , Polymorphism, Genetic/*genetics, Adult ; Aged ; Drug Combinations ; Female ; Heterozygote ; Humans ; Irinotecan/pharmacology ; Male ; Middle Aged ; Oxaliplatin

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Tabuse, Hiroyuki, Kashiwagi, Hiroya, Hamauchi, Satoshi, Tsushima, Takahiro, Todaka, Akiko, Yokota, Tomoya, Machida, Nozomu, Yamazaki, Kentaro, Fukutomi, Akira, Onozawa, Yusuke, Mori, Keita, Boku, Narikazu, Ichinose, Masao, Yasui, Hirofumi

المصدر: Gastric Cancer; Jul2016, Vol. 19 Issue 3, p894-901, 8p

مصطلحات موضوعية: STOMACH cancer treatment, EYE diseases, CHEMOTHERAPY complications, STOMACH cancer patients, FLUOROURACIL, ADVERSE health care events, DISEASE risk factors

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Shimoyama, Rai, Yasui, Hirofumi, Boku, Narikazu, Onozawa, Yusuke, Hironaka, Shuichi, Fukutomi, Akira, Yamazaki, Kentaro, Taku, Keisei, Kojima, Takashi, Machida, Nozomu, Todaka, Akiko, Tomita, Hideharu, Sakamoto, Takeshi, Tsushima, Takahiro

المصدر: Gastric Cancer; Dec2009, Vol. 12 Issue 4, p206-211, 6p, 3 Charts, 2 Graphs

مصطلحات موضوعية: STOMACH cancer, PACLITAXEL, FLUOROURACIL, CISPLATIN, CANCER chemotherapy